Smith & Nephew Aktie

Smith & Nephew für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 502816 / ISIN: GB0009223206

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
30.10.2014 13:19:11

Smith & Nephew Q3 Profit Slides - Quick Facts

(RTTNews) - Medical technology company Smith & Nephew Plc. (SN.L, SNN) Thursday said third-quarter attributable profit declined to $102 million from $122 million. Earnings per share were 11.3 cents, compared to 13.5 cents last year.

Profit before taxation dropped to $153 million from $178 million.

Revenue increased to $1.148 billion from $1.027 billion in the prior year. Group revenue growth from Established Markets was flat.

Olivier Bohuon, CEO, said, "Sports Medicine Joint Repair and Advanced Wound Bioactives both produced double-digit growth in the quarter, and the emerging markets business increased revenue by 20%. We are pleased with our momentum..."

Further, the company said outlook for the Group for the full year remains unchanged.

Analysen zu Smith & Nephew plcmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Smith & Nephew plc 12,30 7,99% Smith & Nephew plc